LGNDLigand Pharmaceuticals Incorporated

$287.86

Who owns LGND

344 institutions reported holding LGND for 2026Q1, together 103% of the company, more than the 340 a quarter earlier.

344

Institutions reporting a position · as of 2026Q1 · up from 340 the quarter before

Shares held by institutions
20.5M

Shares held by institutions · 103% of the company · long US equity positions only, as reported on Form 13F

Reported value
$4.10B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
39%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
52
New positions
47
Positions exited
46
Added to
120
Reduced
109
Top 10 holdersof the company
53%
Institutional ownership by quarter, 2013Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q134420.5M$4.10B
2025Q434020.4M$3.86B
2025Q330820.4M$3.62B
2025Q226619.1M$2.18B
2025Q125718.7M$1.97B
2024Q425518.2M$1.95B
2024Q323818.1M$1.81B
2024Q223217.2M$1.45B
2024Q121916.5M$1.20B
2023Q420916.1M$1.15B
2023Q319315.6M$936M
2023Q220215.6M$1.12B
2023Q120914.8M$1.09B
2022Q419614.7M$983M
2022Q320314.8M$1.28B
2022Q219414.9M$1.33B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.3.0M15%$591M
VANGUARD GROUP INC2.1M11%$421M
HENDERSON GROUP PLC1.0M5.1%$202M
Invesco Ltd.0.8M4.1%$164M
STATE STREET CORP0.8M3.9%$155M
FMR LLC0.6M3.0%$119M
NOMURA HOLDINGS INC0.6M2.9%$114M
FRANKLIN RESOURCES INC0.6M2.9%$114M
Chicago Capital, LLC0.6M2.8%$112M
GEODE CAPITAL MANAGEMENT LLC0.6M2.8%$112M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…